Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00058-3/fulltext?dgcid=hubspot_update_feature_updatealerts_lanepe&utm_campaign=update-lanepe&utm_medium=email&_hsmi=266522984&_hsenc=p2ANqtz---OgFdnhaFY5lVEKEQToA5pjadG4PyY8V7jL2mXWSPky2vfojat82GI5FHsqUoL2LthBbRmHms2cXlySi6at36zsyL9A&utm_content=266163766&utm_source=hs_email